Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia
Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (15 cycles) venetoclax/ pirtobrutinib vs. MRD-guided venetoclax/ pirtobrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL) aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes (CLL18/MOIRAI)
Sponsor University Of Cologne
- Start (EU)
- Latest update
- Estimated end
Safety and efficacy of treatment combination with ponatinib and asciminib in chronic myeloid leukemia patients resistant to ponatinib and/or asciminib
Sponsor Grupo Espanol De Leucemia Mieloide Cronica (GELMC)
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase II, open-label, multicenter study of orally administered RVU120 for the treatment of anemia in patients with lower-risk myelodysplastic neoplasms (MDS)
Sponsor GCP-Service International West GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase II study of standard of care therapy azacitidine (AZA) combined with venetoclax (VEN) and Tagraxofusp (TAG) in patients with higher-Risk chronic myelomonocytic Leukemia (CMML): the PATROL Study
Sponsor GCP-Service International West GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia?
The 2026-10-09 snapshot links Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia to 4 distinct CTIS trials. Recorded services include Clinical monitoring, contracts with sites, Investigator recruitment, Project management, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia conducted?
The linked trials record locations in 14 countries, including Spain, Germany, Italy, France, Poland. These are trial locations, not confirmed office locations or countries where Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia delivered services.
What can this page tell me about Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia S.L.